If technology-enabled visibility isn’t built into the pharma supply chain today, then manufacturers, distributors, wholesalers, shippers and pharmacies risk significant losses.
Lineage Logistics Holdings, a provider of temperature-controlled logistics solutions, recently announced it has signed definitive agreements to acquire Emergent Cold.
With greater reliance on trading partners, complex supply networks and customer demands, running an intelligent supply chain has never been more vital. Explore the value of linking direct spend sourcing with design, manufacturing and planning processes to build an intelligent digital supply chain.
The trade standoff between the U.S. and China has yet to seriously impact the pharmaceutical and life sciences industries. But as neither side shows signs of backing down, and tariffs continue to be levied on virtually every segment, those sectors are preparing for a major supply-chain disruption.
China and the U.S. plan to highlight joint efforts to crack down on fentanyl smuggling, addressing an opioid epidemic that President Trump has asked his counterpart Xi Jinping to help alleviate as part of broader trade talks.
Regulators want to reduce U.S. dependence on foreign-made pharmaceutical ingredients, as a wave of recalls has raised questions about the safety of the global drug-supply chain.
China’s aggressive campaign to bring down drug prices is leading to a “vicious cycle” and will prevent the emergence of a national pharmaceutical champion, said one of the country’s biggest drug makers.
Alphabet Inc. offshoot Wing, which just received an expanded certification to act as a small air carrier, is starting the nation’s inaugural delivery service via a small civilian aircraft with partners Walgreens and FedEx.
While most business leaders want to avoid a no-deal departure, continued uncertainty is not much better. With the cliff edge looming, and the prospect of another one in three months if the EU grants Parliament’s request for a further delay, collateral damage is mounting.
The three major U.S. pharmacy chains are removing versions of the heartburn drug Zantac from store shelves as health regulators investigate a probable carcinogen detected in the popular stomach drugs.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.